Royal Bank of Canada
CAMP icon

Royal Bank of Canada’s CAMP4 Therapeutics CAMP Stock Holding History

Royal Bank of Canada’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
236
+218
+1,211% +$1.03K ﹤0.01% 6833
2025
Q4 		$0 Sell
18
-935
-98% -$3.98K ﹤0.01% 7191
2025
Q3 		$3K Hold
953
– – ﹤0.01% 6789
2025
Q2 		$2K Buy
953
+533
+127% +$1.06K ﹤0.01% 6784
2025
Q1 		$2K Sell
420
-84
-17% -$406 ﹤0.01% 6554
2024
Q4 		$2K Buy
+504
New +$4.14K ﹤0.01% 6696

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royal Bank of Canada's CAMP Position: Q1 2026 in Review

Royal Bank of Canada increased its CAMP4 Therapeutics (CAMP) stake by 1,211% in Q1 2026, buying an estimated $1.03K and bringing the position to 236 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6833.

Royal Bank of Canada first reported a position in CAMP in Q4 2024 and has held it in 6 quarters since. The position peaked at $3K in Q3 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Royal Bank of Canada held 236 shares of CAMP4 Therapeutics worth $1K as of Q1 2026.
  • Royal Bank of Canada bought 218 CAMP4 Therapeutics shares in Q1 2026, an estimated $1.03K.
  • CAMP4 Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6833 holding.
  • Royal Bank of Canada first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Royal Bank of Canada's CAMP4 Therapeutics position peaked at $3K in Q3 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.